Back to Search Start Over

Substandard and falsified medicines:Proposed methods for case finding and sentinel surveillance

Authors :
Pisani, Elizabeth
Hasnida, Amalia
Rahmi, Mawaddati
Kok, Maarten Olivier
Harsono, Steven
Anggriani, Yusi
Pisani, Elizabeth
Hasnida, Amalia
Rahmi, Mawaddati
Kok, Maarten Olivier
Harsono, Steven
Anggriani, Yusi
Source :
Pisani , E , Hasnida , A , Rahmi , M , Kok , M O , Harsono , S & Anggriani , Y 2021 , ' Substandard and falsified medicines : Proposed methods for case finding and sentinel surveillance ' , JMIR Public Health and Surveillance , vol. 7 , no. 8 , e29309 .
Publication Year :
2021

Abstract

The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries. However, no country has measured the market-wide extent of the problem, and no standardized methods exist to estimate the prevalence of either substandard or falsified medicines. This is, in part, because the task seems overwhelming; medicine markets are huge and diverse, and testing medicines is expensive. Many countries do operate some form of postmarket surveillance of medicine, but their methods and goals differ. There is currently no clear guidance on which surveillance method is most appropriate to meet specific public health goals. In this viewpoint, we aimed to discuss the utility of both case finding and risk-based sentinel surveillance for substandard and falsified medicines, linking each to specific public health goals. We posit that choosing the system most appropriate to the goal, as well as implementing it with a clear understanding of the factors driving the production and sale of substandard and falsified medicines, will allow for surveillance resources to be concentrated most efficiently. We adapted principles used for disease outbreak responses to suggest a case-finding system that uses secondary data to flag poor-quality medicines, proposing risk-based indicators that differ for substandard and falsified medicines. This system potentially offers a cost-effective way of identifying “cases” for market withdrawal, enhanced oversight, or another immediate response. We further proposed a risk-based sentinel surveillance system that concentrates resources on measuring the prevalence of substandard and falsified medicines in the risk clusters where they are most likely to be found. The sentinel surveillance system provides base data for a transparent, spreadsheet-based model for estimating the national prevalence of substandard and falsified medicines. The methods we proposed are based on o

Details

Database :
OAIster
Journal :
Pisani , E , Hasnida , A , Rahmi , M , Kok , M O , Harsono , S & Anggriani , Y 2021 , ' Substandard and falsified medicines : Proposed methods for case finding and sentinel surveillance ' , JMIR Public Health and Surveillance , vol. 7 , no. 8 , e29309 .
Notes :
application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1313637617
Document Type :
Electronic Resource